Vaxcyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxcyte and other ETFs, options, and stocks.About PCVX
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.
CEOGrant E. Pickering
CEOGrant E. Pickering
Employees414
Employees414
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2013
Founded2013
Employees414
Employees414
PCVX Key Statistics
Market cap6.38B
Market cap6.38B
Price-Earnings ratio-9.25
Price-Earnings ratio-9.25
Dividend yield—
Dividend yield—
Average volume1.41M
Average volume1.41M
High today$49.87
High today$49.87
Low today$45.62
Low today$45.62
Open price$45.62
Open price$45.62
Volume2.16M
Volume2.16M
52 Week high$98.17
52 Week high$98.17
52 Week low$27.66
52 Week low$27.66
Stock Snapshot
As of today, Vaxcyte(PCVX) shares are valued at $48.69. The company's market cap stands at 6.38B, with a P/E ratio of -9.25.
During the trading session on 2025-11-14, Vaxcyte(PCVX) shares reached a daily high of $49.87 and a low of $45.62. At a current price of $48.69, the stock is +6.7% higher than the low and still -2.4% under the high.
Trading volume for Vaxcyte(PCVX) stock has reached 2.16M, versus its average volume of 1.41M.
The stock's 52-week range extends from a low of $27.66 to a high of $98.17.
The stock's 52-week range extends from a low of $27.66 to a high of $98.17.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own PCVX. This list is generated using Robinhood data, and it’s not a recommendation.